Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. The drug was developed by AnorMED which was subsequently bought by Genzyme.

CAS：155148-31-5
中文别名：AMD 3100辛基盐酸盐;1,1\'-[1,4-亚苯基双(亚甲基)]双[1,4,8,11-四氮杂环十四烷];
英文别名：AMD 3100 octahydrochloride,1,1\'-[1,4-Phenylenebis-(methylene)]-bis-(1,4,8,11-tetraazacyclotetradecane)octahydrochloride;Plerixafor 8HCl (AMD3100 8HCl);1,4,8,11-Tetraazacyclotetradecane (1,1\'-[1,4-phenylenebis(methylene)]bis;
分子式：C28H62Cl8N8
分子量：794.469
精确质量：790.261
Psa：78.66
Logp：8.6804

UNII：OD49913540

密度：0.962g/cm3
沸点：657.5ºC at 760mmHg
闪点：361.8ºC
储存条件：-20ºC
蒸汽压：2.85E-33mmHg at 25°C

安全说明：S22; S24/25

用途
普乐沙福治疗骨髓瘤药物。